Enoxaparin dose reduction for thrombocytopenia in patients with cancer: a quality assessment study

The development of thrombocytopenia in the setting of therapeutic anticoagulation for venous thromboembolic disease (VTE) is common in cancer patients, but guidelines for management are based on limited past data and have not been validated. In 2011, Memorial Sloan Kettering Cancer Center (MSKCC) im...

Descripción completa

Detalles Bibliográficos
Autores principales: Mantha, Simon, Miao, Yimei, Wills, Jonathan, Parameswaran, Rekha, Soff, Gerald A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5375964/
https://www.ncbi.nlm.nih.gov/pubmed/28205078
http://dx.doi.org/10.1007/s11239-017-1478-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5375964/
https://www.ncbi.nlm.nih.gov/pubmed/28205078
http://dx.doi.org/10.1007/s11239-017-1478-0

Ejemplares similares